BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31921129)

  • 1. Capacity to Elicit Cytotoxic CD8 T Cell Activity Against
    Franceschi V; Mahmoud AH; Abdellrazeq GS; Tebaldi G; Macchi F; Russo L; Fry LM; Elnaggar MM; Bannantine JP; Park KT; Hulubei V; Cavirani S; Davis WC; Donofrio G
    Front Immunol; 2019; 10():2859. PubMed ID: 31921129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A peptide-based vaccine for Mycobacterium avium subspecies paratuberculosis.
    Abdellrazeq GS; Elnaggar MM; Bannantine JP; Schneider DA; Souza CD; Hwang J; Mahmoud AHA; Hulubei V; Fry LM; Park KT; Davis WC
    Vaccine; 2019 May; 37(21):2783-2790. PubMed ID: 31003915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous cognate epitope recognition by bovine CD4 and CD8 T cells is essential for primary expansion of antigen-specific cytotoxic T-cells following ex vivo stimulation with a candidate Mycobacterium avium subsp. paratuberculosis peptide vaccine.
    Abdellrazeq GS; Fry LM; Elnaggar MM; Bannantine JP; Schneider DA; Chamberlin WM; Mahmoud AHA; Park KT; Hulubei V; Davis WC
    Vaccine; 2020 Feb; 38(8):2016-2025. PubMed ID: 31902643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Mycobacterium avium subsp. paratuberculosis relA deletion mutant and a 35 kDa major membrane protein elicit development of cytotoxic T lymphocytes with ability to kill intracellular bacteria.
    Abdellrazeq GS; Elnaggar MM; Bannantine JP; Park KT; Souza CD; Backer B; Hulubei V; Fry LM; Khaliel SA; Torky HA; Schneider DA; Davis WC
    Vet Res; 2018 Jun; 49(1):53. PubMed ID: 29941017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of two mutants of Mycobacterium avium subsp. paratuberculosis as candidates for a live attenuated vaccine for Johne's disease.
    Park KT; Allen AJ; Bannantine JP; Seo KS; Hamilton MJ; Abdellrazeq GS; Rihan HM; Grimm A; Davis WC
    Vaccine; 2011 Jun; 29(29-30):4709-19. PubMed ID: 21565243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of relA abrogates the capacity of Mycobacterium avium paratuberculosis to establish an infection in calves.
    Park KT; Allen AJ; Barrington GM; Davis WC
    Front Cell Infect Microbiol; 2014; 4():64. PubMed ID: 24860792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. relA is Achilles' heel for mycobacterial pathogens as demonstrated with deletion mutants in Mycobacterium avium subsp. paratuberculosis and mycobacterium bovis bacillus Calmette-Guérin (BCG).
    Abdellrazeq GS; Mahmoud AH; Park KT; Fry LM; Elnaggar MM; Schneider DA; Hulubei V; Davis WC
    Tuberculosis (Edinb); 2020 Jan; 120():101904. PubMed ID: 32090858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Salmonella vectored vaccine expressing Mycobacterium avium subsp. paratuberculosis antigens against challenge in a goat model.
    Faisal SM; Yan F; Chen TT; Useh NM; Guo S; Yan W; Wang SJ; Glaser AL; McDonough SP; Singh B; Chang YF
    PLoS One; 2013; 8(8):e70171. PubMed ID: 23950909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the cell-mediated immune response to reduced doses of Mycobacterium avium ssp. paratuberculosis vaccine in cattle.
    Platt R; Thoen CO; Stalberger RJ; Chiang YW; Roth JA
    Vet Immunol Immunopathol; 2010 Jul; 136(1-2):122-6. PubMed ID: 20193967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with recombinant Mycobacterium avium subsp. paratuberculosis proteins induces differential immune responses and protects calves against infection by oral challenge.
    Kathaperumal K; Park SU; McDonough S; Stehman S; Akey B; Huntley J; Wong S; Chang CF; Chang YF
    Vaccine; 2008 Mar; 26(13):1652-63. PubMed ID: 18304707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring responses by use of five-color flow cytometry in subsets of peripheral T cells obtained from cattle inoculated with a killed Mycobacterium avium subsp paratuberculosis vaccine.
    Platt R; Roth JA; Royer RL; Thoen CO
    Am J Vet Res; 2006 Dec; 67(12):2050-8. PubMed ID: 17144810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the immune response to Mycobacterium avium subsp. paratuberculosis in experimentally infected calves.
    Koo HC; Park YH; Hamilton MJ; Barrington GM; Davies CJ; Kim JB; Dahl JL; Waters WR; Davis WC
    Infect Immun; 2004 Dec; 72(12):6870-83. PubMed ID: 15557608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a Mycobacterium avium subsp. paratuberculosis leuD mutant as a vaccine candidate against challenge in a caprine model.
    Faisal SM; Chen JW; Yan F; Chen TT; Useh NM; Yan W; Guo S; Wang SJ; Glaser AL; McDonough SP; Singh B; Davis WC; Akey BL; Chang YF
    Clin Vaccine Immunol; 2013 Apr; 20(4):572-81. PubMed ID: 23408524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate IFN-gamma production in cattle in response to MPP14, a secreted protein from Mycobacterium avium subsp. Paratuberculosis.
    Olsen I; Storset AK
    Scand J Immunol; 2001 Sep; 54(3):306-13. PubMed ID: 11555395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembled particulate vaccine elicits strong immune responses and reduces Mycobacterium avium subsp. paratuberculosis infection in mice.
    Gupta SK; Parlane NA; Luo D; Rehm BHA; Heiser A; Buddle BM; Wedlock DN
    Sci Rep; 2020 Dec; 10(1):22289. PubMed ID: 33339863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bovine macrophage screening system for identifying attenuated transposon mutants of Mycobacterium avium subsp. paratuberculosis with vaccine potential.
    Scandurra GM; Young M; de Lisle GW; Collins DM
    J Microbiol Methods; 2009 Apr; 77(1):58-62. PubMed ID: 19386227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WC1
    Albarrak SM; Waters WR; Stabel JR; Hostetter JM
    Vet Immunol Immunopathol; 2017 Aug; 190():57-64. PubMed ID: 28778324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel oral vaccine against Mycobacterium avium paratuberculosis and Johne disease: a patho-biotechnological approach.
    Johnston C; Coffey A; O' Mahony J; Sleator RD
    Bioeng Bugs; 2010; 1(3):155-63. PubMed ID: 21326921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity, safety and protection of an Adenovirus 5 prime--Modified Vaccinia virus Ankara boost subunit vaccine against Mycobacterium avium subspecies paratuberculosis infection in calves.
    Bull TJ; Vrettou C; Linedale R; McGuinnes C; Strain S; McNair J; Gilbert SC; Hope JC
    Vet Res; 2014 Oct; 45(1):112. PubMed ID: 25480162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rational framework for evaluating the next generation of vaccines against Mycobacterium avium subspecies paratuberculosis.
    Bannantine JP; Hines ME; Bermudez LE; Talaat AM; Sreevatsan S; Stabel JR; Chang YF; Coussens PM; Barletta RG; Davis WC; Collins DM; Gröhn YT; Kapur V
    Front Cell Infect Microbiol; 2014; 4():126. PubMed ID: 25250245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.